Publication identifier(s): 20457606
Bidirectional lipid inositolphosphotransferase (experimentally validated). Homologous to animal phosphatidylcholine:ceramide cholinephosphotransferases. Expanded on the Trypanosoma lineage.
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 15 |
NetGPI | no | yes: 0, no: 15 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 16 |
GO:0110165 | cellular anatomical entity | 1 | 16 |
GO:0005768 | endosome | 7 | 1 |
GO:0005794 | Golgi apparatus | 5 | 1 |
GO:0005886 | plasma membrane | 3 | 1 |
GO:0020016 | ciliary pocket | 2 | 1 |
GO:0031410 | cytoplasmic vesicle | 6 | 1 |
GO:0031982 | vesicle | 4 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0097708 | intracellular vesicle | 5 | 1 |
Related structures:
AlphaFold database: A4HNG1
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 16 |
GO:0006643 | membrane lipid metabolic process | 4 | 16 |
GO:0006665 | sphingolipid metabolic process | 4 | 16 |
GO:0006793 | phosphorus metabolic process | 3 | 16 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 16 |
GO:0006807 | nitrogen compound metabolic process | 2 | 16 |
GO:0008152 | metabolic process | 1 | 16 |
GO:0009987 | cellular process | 1 | 16 |
GO:0016310 | phosphorylation | 5 | 16 |
GO:0044237 | cellular metabolic process | 2 | 16 |
GO:0044238 | primary metabolic process | 2 | 16 |
GO:0044255 | cellular lipid metabolic process | 3 | 16 |
GO:0071704 | organic substance metabolic process | 2 | 16 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 16 |
GO:0006066 | alcohol metabolic process | 3 | 1 |
GO:0006576 | biogenic amine metabolic process | 5 | 1 |
GO:0006580 | ethanolamine metabolic process | 5 | 1 |
GO:0006672 | ceramide metabolic process | 4 | 1 |
GO:0008610 | lipid biosynthetic process | 4 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009308 | amine metabolic process | 4 | 1 |
GO:0009309 | amine biosynthetic process | 5 | 1 |
GO:0030148 | sphingolipid biosynthetic process | 5 | 1 |
GO:0034308 | primary alcohol metabolic process | 4 | 1 |
GO:0034309 | primary alcohol biosynthetic process | 5 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0042401 | biogenic amine biosynthetic process | 6 | 1 |
GO:0042439 | ethanolamine-containing compound metabolic process | 4 | 1 |
GO:0043603 | amide metabolic process | 3 | 1 |
GO:0043604 | amide biosynthetic process | 4 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 1 |
GO:0044281 | small molecule metabolic process | 2 | 1 |
GO:0044283 | small molecule biosynthetic process | 3 | 1 |
GO:0046165 | alcohol biosynthetic process | 4 | 1 |
GO:0046335 | ethanolamine biosynthetic process | 6 | 1 |
GO:0046467 | membrane lipid biosynthetic process | 4 | 1 |
GO:0046513 | ceramide biosynthetic process | 5 | 1 |
GO:1901160 | primary amino compound metabolic process | 4 | 1 |
GO:1901162 | primary amino compound biosynthetic process | 5 | 1 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
GO:1901615 | organic hydroxy compound metabolic process | 3 | 1 |
GO:1901617 | organic hydroxy compound biosynthetic process | 4 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 16 |
GO:0016301 | kinase activity | 4 | 16 |
GO:0016740 | transferase activity | 2 | 16 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 16 |
GO:0016780 | phosphotransferase activity, for other substituted phosphate groups | 4 | 16 |
GO:0033188 | sphingomyelin synthase activity | 5 | 6 |
GO:0047493 | ceramide cholinephosphotransferase activity | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 11 | 13 | PF00675 | 0.454 |
CLV_NRD_NRD_1 | 142 | 144 | PF00675 | 0.391 |
CLV_PCSK_KEX2_1 | 142 | 144 | PF00082 | 0.387 |
CLV_PCSK_KEX2_1 | 148 | 150 | PF00082 | 0.364 |
CLV_PCSK_PC1ET2_1 | 148 | 150 | PF00082 | 0.355 |
CLV_PCSK_SKI1_1 | 132 | 136 | PF00082 | 0.304 |
CLV_PCSK_SKI1_1 | 157 | 161 | PF00082 | 0.261 |
CLV_PCSK_SKI1_1 | 36 | 40 | PF00082 | 0.401 |
DEG_APCC_KENBOX_2 | 12 | 16 | PF00400 | 0.565 |
DOC_ANK_TNKS_1 | 5 | 12 | PF00023 | 0.578 |
DOC_CDC14_PxL_1 | 65 | 73 | PF14671 | 0.390 |
DOC_CYCLIN_yCln2_LP_2 | 39 | 45 | PF00134 | 0.354 |
DOC_MAPK_DCC_7 | 63 | 73 | PF00069 | 0.318 |
DOC_MAPK_FxFP_2 | 237 | 240 | PF00069 | 0.365 |
DOC_MAPK_gen_1 | 148 | 156 | PF00069 | 0.585 |
DOC_MAPK_MEF2A_6 | 149 | 158 | PF00069 | 0.365 |
DOC_MAPK_MEF2A_6 | 192 | 200 | PF00069 | 0.344 |
DOC_MAPK_MEF2A_6 | 36 | 43 | PF00069 | 0.296 |
DOC_MAPK_NFAT4_5 | 36 | 44 | PF00069 | 0.401 |
DOC_PP1_RVXF_1 | 130 | 136 | PF00149 | 0.592 |
DOC_PP1_RVXF_1 | 76 | 82 | PF00149 | 0.277 |
DOC_PP2B_LxvP_1 | 39 | 42 | PF13499 | 0.187 |
DOC_PP4_FxxP_1 | 237 | 240 | PF00568 | 0.545 |
DOC_USP7_MATH_1 | 260 | 264 | PF00917 | 0.290 |
DOC_USP7_MATH_1 | 348 | 352 | PF00917 | 0.677 |
DOC_USP7_MATH_1 | 354 | 358 | PF00917 | 0.643 |
DOC_WW_Pin1_4 | 232 | 237 | PF00397 | 0.428 |
DOC_WW_Pin1_4 | 331 | 336 | PF00397 | 0.725 |
LIG_14-3-3_CanoR_1 | 125 | 131 | PF00244 | 0.501 |
LIG_14-3-3_CanoR_1 | 157 | 163 | PF00244 | 0.296 |
LIG_14-3-3_CanoR_1 | 244 | 250 | PF00244 | 0.315 |
LIG_14-3-3_CanoR_1 | 262 | 271 | PF00244 | 0.164 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.611 |
LIG_deltaCOP1_diTrp_1 | 74 | 81 | PF00928 | 0.351 |
LIG_eIF4E_1 | 162 | 168 | PF01652 | 0.189 |
LIG_eIF4E_1 | 265 | 271 | PF01652 | 0.243 |
LIG_FHA_1 | 219 | 225 | PF00498 | 0.296 |
LIG_FHA_1 | 264 | 270 | PF00498 | 0.236 |
LIG_FHA_1 | 277 | 283 | PF00498 | 0.287 |
LIG_FHA_1 | 29 | 35 | PF00498 | 0.429 |
LIG_FHA_1 | 313 | 319 | PF00498 | 0.740 |
LIG_FHA_1 | 344 | 350 | PF00498 | 0.732 |
LIG_FHA_1 | 359 | 365 | PF00498 | 0.757 |
LIG_FHA_1 | 84 | 90 | PF00498 | 0.368 |
LIG_FHA_1 | 94 | 100 | PF00498 | 0.397 |
LIG_FHA_2 | 116 | 122 | PF00498 | 0.583 |
LIG_Integrin_isoDGR_2 | 56 | 58 | PF01839 | 0.569 |
LIG_LIR_Apic_2 | 235 | 240 | PF02991 | 0.537 |
LIG_LIR_Gen_1 | 160 | 170 | PF02991 | 0.324 |
LIG_LIR_Gen_1 | 254 | 260 | PF02991 | 0.296 |
LIG_LIR_Nem_3 | 160 | 165 | PF02991 | 0.331 |
LIG_LIR_Nem_3 | 233 | 237 | PF02991 | 0.471 |
LIG_LIR_Nem_3 | 254 | 259 | PF02991 | 0.325 |
LIG_LIR_Nem_3 | 279 | 283 | PF02991 | 0.288 |
LIG_LIR_Nem_3 | 338 | 342 | PF02991 | 0.577 |
LIG_LIR_Nem_3 | 44 | 50 | PF02991 | 0.356 |
LIG_MYND_1 | 236 | 240 | PF01753 | 0.537 |
LIG_PCNA_PIPBox_1 | 152 | 161 | PF02747 | 0.365 |
LIG_PCNA_yPIPBox_3 | 148 | 159 | PF02747 | 0.365 |
LIG_Pex14_2 | 228 | 232 | PF04695 | 0.402 |
LIG_Pex14_2 | 237 | 241 | PF04695 | 0.519 |
LIG_Pex14_2 | 43 | 47 | PF04695 | 0.238 |
LIG_PTB_Apo_2 | 113 | 120 | PF02174 | 0.562 |
LIG_SH2_CRK | 162 | 166 | PF00017 | 0.298 |
LIG_SH2_CRK | 24 | 28 | PF00017 | 0.593 |
LIG_SH2_CRK | 256 | 260 | PF00017 | 0.306 |
LIG_SH2_CRK | 280 | 284 | PF00017 | 0.331 |
LIG_SH2_PTP2 | 274 | 277 | PF00017 | 0.439 |
LIG_SH2_STAP1 | 162 | 166 | PF00017 | 0.302 |
LIG_SH2_STAP1 | 265 | 269 | PF00017 | 0.236 |
LIG_SH2_STAT5 | 105 | 108 | PF00017 | 0.389 |
LIG_SH2_STAT5 | 256 | 259 | PF00017 | 0.303 |
LIG_SH2_STAT5 | 265 | 268 | PF00017 | 0.223 |
LIG_SH2_STAT5 | 274 | 277 | PF00017 | 0.287 |
LIG_SH3_1 | 63 | 69 | PF00018 | 0.256 |
LIG_SH3_3 | 246 | 252 | PF00018 | 0.449 |
LIG_SH3_3 | 319 | 325 | PF00018 | 0.714 |
LIG_SH3_3 | 4 | 10 | PF00018 | 0.698 |
LIG_SH3_3 | 63 | 69 | PF00018 | 0.270 |
LIG_Sin3_3 | 168 | 175 | PF02671 | 0.357 |
LIG_SUMO_SIM_anti_2 | 163 | 168 | PF11976 | 0.216 |
LIG_SUMO_SIM_anti_2 | 315 | 323 | PF11976 | 0.717 |
LIG_SUMO_SIM_anti_2 | 86 | 92 | PF11976 | 0.347 |
LIG_SUMO_SIM_par_1 | 170 | 177 | PF11976 | 0.291 |
LIG_SUMO_SIM_par_1 | 198 | 204 | PF11976 | 0.303 |
LIG_TYR_ITSM | 158 | 165 | PF00017 | 0.402 |
LIG_UBA3_1 | 363 | 367 | PF00899 | 0.584 |
LIG_UBA3_1 | 72 | 78 | PF00899 | 0.392 |
LIG_WW_2 | 66 | 69 | PF00397 | 0.249 |
MOD_CK1_1 | 218 | 224 | PF00069 | 0.287 |
MOD_CK1_1 | 263 | 269 | PF00069 | 0.279 |
MOD_CK1_1 | 330 | 336 | PF00069 | 0.573 |
MOD_CK1_1 | 369 | 375 | PF00069 | 0.719 |
MOD_CK2_1 | 115 | 121 | PF00069 | 0.578 |
MOD_CK2_1 | 281 | 287 | PF00069 | 0.187 |
MOD_CMANNOS | 300 | 303 | PF00535 | 0.418 |
MOD_Cter_Amidation | 10 | 13 | PF01082 | 0.375 |
MOD_Cter_Amidation | 140 | 143 | PF01082 | 0.399 |
MOD_GlcNHglycan | 139 | 142 | PF01048 | 0.386 |
MOD_GlcNHglycan | 206 | 209 | PF01048 | 0.540 |
MOD_GlcNHglycan | 217 | 220 | PF01048 | 0.234 |
MOD_GlcNHglycan | 328 | 332 | PF01048 | 0.521 |
MOD_GlcNHglycan | 350 | 353 | PF01048 | 0.480 |
MOD_GlcNHglycan | 356 | 359 | PF01048 | 0.511 |
MOD_GSK3_1 | 174 | 181 | PF00069 | 0.330 |
MOD_GSK3_1 | 281 | 288 | PF00069 | 0.410 |
MOD_GSK3_1 | 327 | 334 | PF00069 | 0.732 |
MOD_GSK3_1 | 350 | 357 | PF00069 | 0.726 |
MOD_N-GLC_1 | 115 | 120 | PF02516 | 0.377 |
MOD_N-GLC_1 | 306 | 311 | PF02516 | 0.285 |
MOD_N-GLC_1 | 93 | 98 | PF02516 | 0.397 |
MOD_N-GLC_2 | 183 | 185 | PF02516 | 0.554 |
MOD_NEK2_1 | 158 | 163 | PF00069 | 0.286 |
MOD_NEK2_1 | 215 | 220 | PF00069 | 0.287 |
MOD_NEK2_1 | 276 | 281 | PF00069 | 0.370 |
MOD_NEK2_1 | 93 | 98 | PF00069 | 0.415 |
MOD_PIKK_1 | 29 | 35 | PF00454 | 0.468 |
MOD_PKA_2 | 354 | 360 | PF00069 | 0.757 |
MOD_Plk_1 | 115 | 121 | PF00069 | 0.602 |
MOD_Plk_1 | 16 | 22 | PF00069 | 0.692 |
MOD_Plk_1 | 93 | 99 | PF00069 | 0.428 |
MOD_Plk_4 | 115 | 121 | PF00069 | 0.621 |
MOD_Plk_4 | 160 | 166 | PF00069 | 0.269 |
MOD_Plk_4 | 198 | 204 | PF00069 | 0.304 |
MOD_Plk_4 | 218 | 224 | PF00069 | 0.109 |
MOD_Plk_4 | 245 | 251 | PF00069 | 0.259 |
MOD_Plk_4 | 93 | 99 | PF00069 | 0.275 |
MOD_ProDKin_1 | 232 | 238 | PF00069 | 0.428 |
MOD_ProDKin_1 | 331 | 337 | PF00069 | 0.725 |
TRG_ENDOCYTIC_2 | 162 | 165 | PF00928 | 0.292 |
TRG_ENDOCYTIC_2 | 234 | 237 | PF00928 | 0.443 |
TRG_ENDOCYTIC_2 | 256 | 259 | PF00928 | 0.296 |
TRG_ENDOCYTIC_2 | 274 | 277 | PF00928 | 0.296 |
TRG_ENDOCYTIC_2 | 280 | 283 | PF00928 | 0.296 |
TRG_ENDOCYTIC_2 | 339 | 342 | PF00928 | 0.576 |
TRG_ER_diArg_1 | 142 | 144 | PF00400 | 0.609 |
TRG_NES_CRM1_1 | 74 | 87 | PF08389 | 0.343 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HRL7 | Leptomonas seymouri | 69% | 100% |
A0A0S4J1W3 | Bodo saltans | 46% | 100% |
A0A1X0P4U9 | Trypanosomatidae | 48% | 100% |
A0A3S7XA07 | Leishmania donovani | 68% | 100% |
A0A422NCN9 | Trypanosoma rangeli | 44% | 100% |
A4IC70 | Leishmania infantum | 68% | 100% |
B3A0L9 | Trypanosoma brucei brucei | 45% | 100% |
B3A0M0 | Trypanosoma brucei brucei | 44% | 100% |
B3A0M1 | Trypanosoma brucei brucei | 44% | 100% |
B3A0M2 | Trypanosoma brucei brucei | 45% | 100% |
C9ZYF5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 100% |
C9ZYF7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 100% |
C9ZYF8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 100% |
C9ZYF9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 100% |
C9ZYG0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 100% |
C9ZYG2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 100% |
E9AFX2 | Leishmania major | 71% | 100% |
E9B725 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 67% | 100% |
Q38E53 | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | 45% | 100% |
Q38E54 | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | 45% | 100% |
Q38E55 | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | 45% | 100% |
Q38E56 | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | 45% | 100% |
Q4E4I4 | Trypanosoma cruzi (strain CL Brener) | 49% | 100% |
Q4JM44 | Rattus norvegicus | 25% | 100% |
Q96LT4 | Homo sapiens | 25% | 93% |
Q9D4B1 | Mus musculus | 25% | 100% |
Q9DA37 | Mus musculus | 24% | 81% |